NOVALIS LIFESCIENCES
Live / Applied — Statement of use — processing complete, to examiner (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 06 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97206199
- Mark type
- Design + words
- Filed
- 06 Jan 2022
- Published for opposition
- 05 Nov 2024
- Attorney of record
- Michael D. Fishman
Goods and services
- Class 036 — Insurance and financial services: Financing services; investment banking services; venture capital and private equity investing; financial consultation; fund management, namely, venture capital fund and private equity fund management, none of the aforesaid services provided in relation to financing any medical treatment plans or health insurance plans to hospitals, pharmacies, healthcare service providers and patients
Owner
- Novalis LifeSciences LLC, Hampton, NH, US
- Novalis LifeSciences LLC, Hampton, NH, US
Prosecution history
- 04 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Dec 2025 — USE AMENDMENT FILED
- 16 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2025 — SOU EXTENSION 1 GRANTED
- 12 Jun 2025 — SOU EXTENSION 1 FILED
- 12 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED